Lichtheimia corymbifera

From WikiMD's WELLNESSPEDIA

Lichtheimia corymbifera is a species of fungus that belongs to the family Lichtheimiaceae. It is a thermophilic fungus, meaning it thrives in high-temperature environments. L. corymbifera is one of the most common causes of mucormycosis, a serious and often deadly fungal infection.

Taxonomy[edit]

Lichtheimia corymbifera was first described in 1896 by German mycologist Karl Lichtheim. The genus name Lichtheimia is derived from his surname, while the species name corymbifera refers to the corymb-like structure of its sporangia.

Description[edit]

L. corymbifera is a saprophytic fungus, meaning it feeds on dead or decaying organic matter. It produces large, round sporangia that are filled with numerous spores. These spores are released into the environment and can cause infection if inhaled or ingested by a susceptible host.

Pathogenicity[edit]

L. corymbifera is a pathogenic fungus that can cause mucormycosis, a serious fungal infection that primarily affects individuals with weakened immune systems. The infection can manifest in various forms, including rhinocerebral, pulmonary, cutaneous, gastrointestinal, and disseminated mucormycosis. Treatment typically involves antifungal medications and surgical debridement of infected tissues.

Epidemiology[edit]

L. corymbifera is found worldwide, but it is most common in tropical and subtropical regions. It is often found in soil, decaying vegetation, and compost piles. Infections are relatively rare but can be severe or fatal, particularly in individuals with weakened immune systems.

Research[edit]

Research on L. corymbifera has focused on understanding its pathogenicity and developing effective treatments for mucormycosis. Recent studies have also explored its potential for biotechnological applications, such as the production of biofuels and enzymes.

This article is a stub related to fungus. You can help WikiMD by expanding it!



Lichtheimia corymbifera[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.